Three PE/VC firms lead financing for AI-driven drug company

SoftBank Vision Fund 2, PICC Capital and Morningside co-led a $318 million financing of XtalPi, an artificial intelligence-based drug discovery and development company based in Massachusetts and . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.